Eltrombopag as bridging therapy to haematopoietic stem cell transplant in severe or very severe aplastic anaemia during the COVID19 pandemic (in adults), NHS England

Aplastic anaemia is a rare and serious bone marrow failure disorder causing a high risk of life-threatening bleeding and infections, and requiring frequent hospital admissions. Current definitive treatments for aplastic anaemia are stem cell transplant or immunosuppressive therapy with antithymocyte globulin and/or ciclosporin. Stem cell transplant is a procedure in which a patient receives healthy stem cells to replace damaged stem cells. Immunosuppressive treatment is where drugs are given to lower the body ' s immune response. Stem cell transplant and antithymocyte globulin treatment require hospital admission
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news